专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

2. 发明申请

WO2014138378A1 NOVEL MIXED μ AGONIST/ δ ANTAGONIST OPIOID ANALGESICS WITH REDUCED TOLERANCE LIABILITIES AND USES THEREOF 审中-公开
标题翻译：新型混合μAGONIST /δANTAGONIST OPIOID ANALGESICS具有降低的容忍负荷及其用途
公开(公告)号：WO2014138378A1
公开(公告)日：2014-09-12
申请号：PCT/US2014/021155
申请日：2014-03-06
申请人： UNIVERSITY OF MARYLAND, BALTIMORE , WEST VIRGINIA UNIVERSITY , COOP, Andrew , MACKERELL, Alexander, D. , MATSUMOTO, Rae
发明人： COOP, Andrew , MACKERELL, Alexander, D. , MATSUMOTO, Rae
IPC分类号： A61K31/485
CPC分类号： C07D489/08 , C07D489/02
摘要： An opioid narcotics used for the treatment of moderate-to-severe pain that primarily exert their analgesic effects through μ receptors. Although, traditional μ agonists can cause undesired side effects, including tolerance, addition of δ antagonists can attenuate said side effects. The present invention includes 4a,9-dihydroxy-7a-(hydroxymethyl)-3 -methyl-2,3,4,4a,5,6-hexahydro-1 H-4, 12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one (UMB 425) a 5,14-bridged morphinan-based orvinol precursor, along with analogs of morphine, dihydromorphine, hydromorphone, codeine, dihydrocodeine, hydrocodone and ethylmorphine. Although UMB 425 lacks δ-specific motifs, conformationally sampled pharmacophore models for μ and δ receptors predict it to have efficacy similar to morphine at μ receptors and similar to naltrexone at δ receptors, due to the compound sampling conformations in which the hydroxyl moiety interacts with the receptors similar to orvinols. UMB 425 exhibits a mixed μ agonist/δ antagonist profile as determined in receptor binding. UMB 425 has mixed μ agonist/δ antagonist properties in vitro that translate to reduced tolerance liabilities in vivo .
摘要翻译：用于治疗主要通过μ受体发挥其镇痛作用的中度至重度疼痛的阿片样麻醉药物。尽管传统的μ激动剂可能引起不希望的副作用，包括耐受性，δ拮抗剂的添加可以减弱所述副作用。本发明包括4a，9-二羟基-7a-（羟甲基）-3-甲基-2,3,4,4a，5,6-六氢-1H-4,12-甲基苯并呋喃并[3,2-e]异喹啉 -7（7aH） - 酮（UMB 425），5,14-桥连的吗啡喃基的月桂醇前体，以及吗啡，二氢吗啡，氢吗啡酮，可待因，二氢可待因，氢可酮和乙基吗啡的类似物。虽然UMB 425缺乏δ特异性基序，但是构象取样的μ和δ受体的药效团模型预测其在μ受体上具有与吗啡相似的功效，并且与δ受体的纳曲酮类似，这是由于羟基部分与类似于orvinols的受体。 UMB 425显示在受体结合中测定的混合μ激动剂/δ拮抗剂谱。 UMB 425在体外具有混合的μ激动剂/δ拮抗剂性质，其在体内转化为降低的耐受负荷。

IPRDB

热门服务

关于我们

友情链接

联系方式